HCA
BMY icon

Harbor Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Harbor Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84K Buy
1,387
+802
+137% +$46.8K 0.01% 655
2025
Q4 		$32K Sell
585
-20
-3% -$962 ﹤0.01% 746
2025
Q3 		$27K Buy
605
+313
+107% +$14.6K ﹤0.01% 743
2025
Q2 		$14K Buy
+292
New +$14.3K ﹤0.01% 863

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbor Capital Advisors's BMY Position: Q1 2026 in Review

Harbor Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 137% in Q1 2026, buying an estimated $46.8K and bringing the position to 1,387 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #655.

Harbor Capital Advisors first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Harbor Capital Advisors held 1,387 shares of Bristol-Myers Squibb worth $84K as of Q1 2026.
  • Harbor Capital Advisors bought 802 Bristol-Myers Squibb shares in Q1 2026, an estimated $46.8K.
  • Bristol-Myers Squibb made up 0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #655 holding.
  • Harbor Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.